Photo via New York Post

New male birth control options are on the way —  including a pill that could make orgasms even better

Read the original at New York Post ↗
Cite

Beard, M. (2026, September 25). New male birth control options are on the way — including a pill that could make orgasms even better. New York Post. https://nypost.com/2026/09/25/health/two-new-male-contraceptives-could-soon-give-guys-more-options/

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

New York Post · collected 2026-09-25 · by McKenzie Beard

Quick Summary

NEXT Life Sciences is developing two new male contraceptive options: PausePill and Plan A. A survey of over 18,000 men in seven countries found that 61% would consider using a new male contraceptive within its first year on the market, including 49% in the US. PausePill is an on-demand pill taken before sex or daily for continuous coverage, designed to prevent sperm release without affecting sexual pleasure; early trials show promising results but require further testing. Plan A involves a reversible implant that uses Vasalgel to block sperm flow while maintaining normal ejaculation and fertility when removed.
Written by AI on 2026-09-25, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

A recent survey across seven countries involving more than 18,000 men found that 61% of respondents would consider using new male contraceptive methods within their first year on the market, including 49% in the US. Responding to this interest, NEXT Life Sciences, a biotech company, is developing two potential options: PausePill, an oral contraceptive taken before sex or daily for continuous coverage, and Plan A, a long-term reversible implant. L.R. Fox, founder of NEXT Life Sciences, reported that over 50,000 men have already signed up to try these methods as soon as they become available, despite limited advertising efforts by the company.

Written for “Male Birth Control Options Developing” on 2026-10-30, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Male Birth Control Options Developing
Health · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
39
sentences that state something as happening or true
Uncertain
5%
2 of 39 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
66/100
New York Post's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-25 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

New York Post · 15208 article(s) · 35 correction(s) detected
Running correction rate · 35 correction(s)

Who wrote this

McKenzie Beard
19 article(s) here · 1 carrying a prediction
🔮 “He has been held in the warm embrace of family and friends, surrounded by live music, prayer, tears, laughter, and the kind of profound emotion that only he could inspire after a lifetime of devotion to us all,” read a statement posted Thursday to Stewart’s Instagram page.
🔮 Today, they’re attracting an increasingly mainstream crowd, with many betting that these once-taboo substances could be the next big thing in mental health.
🔮 Zyn may have taken nicotine pouches mainstream, but we’ve come a long way since the brand popularized the “lip pillow.”
🔮 But that scan may reveal more than just how the girls are doing.
🔮 Holding your breath may be more than just a good party trick.
🔮 The findings, from Canada, could be a warning sign for the US, where the activity has taken off in recent years.
🔮 “I was searching for a magical reset button where I didn’t have to take time off and it would take care of all of my misbehavior and all of my poor choices would be erased and I would feel anew again,” Stratton, who lives in Palm City, Florida, said.
🔮 Its restaurant, Votana, is set to open Oct. 15 and will serve dishes inspired by the coastal cuisines of California, Greece, Italy, Spain and Southern France.
🔮 A 2024 survey of more than 18,000 men across seven countries found that 61% would consider trying a new male contraceptive within its first year on the market, including 49% of those in the US.
🔮 “He asked me where I was and I couldn’t tell him,” Corn, 56, told The Post.
Also by McKenzie Beard
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 19 articles by McKenzie Beard →

Topics

NEXT NEXT Life Sciences PausePill Plan A The Post

Subjects

Fox ORG · 5× NEXT ORG · 4× NEXT Life Sciences ORG · 2× L.R. Fox PERSON · 1× The Post ORG · 1×

Narrative

One company looking to capitalize on that interest is NEXT Life Sciences, which is working on two potential options: PausePill, an on-demand drug taken before sex, and Plan A, a reversible implant designed to keep sperm at bay for years.
framing: assertive · carried by 1 article(s) · first seen 2026-09-25
🔮 A 2024 survey of more than 18,000 men across seven countries found that 61% would consider trying a new male contraceptive within its first year on the market, including 49% of those in the US.

Claims (39 extracted, 2 hedged)

And apparently, plenty of guys are eager to give them a shot. asserted
plenty → give → shot
A 2024 survey of more than 18,000 men across seven countries found that 61% would consider trying a new male contraceptive within its first year on the market, including 49% of those in the US. asserted
% → find → US
One company looking to capitalize on that interest is NEXT Life Sciences, which is working on two potential options: PausePill, an on-demand drug taken before sex, and Plan A, a reversible implant designed to keep sperm at bay for years. asserted
which → look → years
“We have 50,000 men who’ve signed up just from word of mouth,” L.R. Fox, founder and chairman of NEXT Life Sciences, told The Post. asserted
Fox → have → Post
“We’re not actively advertising. asserted
We → advertise → ?
People are signing up and saying, ‘as soon as it’s available, please.’” Here’s everything you need to know about the two novel birth control methods — including one that may make orgasms even more pleasurable. Male birth control for when you need it PausePill is a non-hormonal, oral contraceptive that aims to provide about 24 hours of birth control. NEXT envisions two ways to take it: a man could pop a pill when he wants protection, or take one every day for continuous coverage. uncertain
he → sign → coverage
The pill works without shutting down sperm production. asserted
pill → work → production
Instead, it interferes with the biological signal that tells the vas deferens — the tubes that carry sperm — to release it during ejaculation. asserted
that → interfere → ejaculation
In theory, the rest of the experience is supposed to stay intact. asserted
rest → suppose → experience
Men would still be able to get an erection, have an orgasm and experience sexual pleasure, even though sperm isn’t released. asserted
sperm → get → pleasure
“In fact, anecdotally, we’ve heard men say that they actually have increased pleasure,” Fox said. asserted
Fox → hear → pleasure
It’s still early days, but in a US Phase 2 trial, PausePill prevented sperm release in 100% of participants who took it within two hours. asserted
who → ’ → hours
The men also reported no meaningful difference in sexual pleasure or function compared with those who received placebo, and there were no major adverse events. asserted
who → report → placebo
Larger trials will be needed to determine how well the drug works — and how safe it is — in a larger group of men and with repeated use. asserted
it → need → use
“We are sprinting towards a larger clinical trial starting at the end of this year, 2026, with hopes to bring it to market within two years,” Fox said. asserted
Fox → sprint → years
If it ultimately gets regulatory approval, PausePill would initially be available by prescription. asserted
PausePill → get → prescription
Set it and forget it For men who’d rather not think about birth control every time they have sex, NEXT is working on Plan A, a reversible implant that could provide longer-term contraception. uncertain
that → set → contraception
“It’s a light switch for fertility,” Fox said. asserted
Fox → ’ → fertility
“When you’re ready, whether it’s three years or five years or 10 years from now, we’ll flip it back on.” asserted
we → ’re → it
Plan A uses Vasalgel, a hydrogel that is inserted into the vas deferens. asserted
that → use → deferens
Rather than cutting the tubes like a vasectomy, the gel forms a flexible barrier that blocks sperm while allowing other fluids to pass through like normal. asserted
fluids → cut → sperm
“A vasectomy permanently shuts off that pipe by cutting it,” Fox said. asserted
Fox → shut → it
“This is just a small little filter that’s put in there.” asserted
that → put → ?
NEXT says the procedure can be done in about 10 minutes in a doctor’s office, where the gel goes through through a tiny puncture without a scalpel or stitches. asserted
gel → say → scalpel
But men won’t be able to ditch their other birth-control methods right away. asserted
men → ditch → methods
Sperm already in the reproductive tract still needs time to clear, which Fox said can take up to three months, roughly the same timeline as a vasectomy. asserted
Fox → need → vasectomy
Men would be advised to continue using another form of birth control until a doctor or at-home test confirms there’s no sperm in the ejaculate. asserted
doctor → advise → ejaculate
And when it’s time to turn fertility back on, NEXT has a separate reversal device with a solution to dissolve the gel. asserted
NEXT → ’ → gel
In an early first-in-human study, 16 men were successfully implanted with Vasalgel. asserted
men → implant → Vasalgel
All reached azoospermia, meaning there was no measurable sperm in their ejaculate, within 14 days. asserted
All → reach → days
“There were no serious adverse events, and everything resolved quickly otherwise,” Fox said. asserted
Fox → be → ?
“In fact, all men were able to return to work immediately.” asserted
men → return → work
A second part of the study is now evaluating whether the implant can be reversed and fertility restored. asserted
fertility → evaluate → study
Previous animal studies of the reversal process have produced positive results, Fox said, making the company have “very, very high confidence” in the regimen. asserted
company → produce → regimen
The push for male birth control isn’t coming from men alone. asserted
push → come → men
A 2023 survey found that two-thirds of American women were interested in having their partners use contraception, citing shared responsibility, an extra layer of protection and avoiding side effects from their own methods. asserted
partners → find → methods
“I believe future generations will look back and be like, in 2026, like how did you not have this?” Fox said. asserted
Fox → believe → this
“It’s about time. asserted
It → ’ → time
Let’s get this done and just make this normal.” asserted
this → let → ?
💬Give feedback
🕘History 🎫Support